Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Owens, David G. C.
Finlayson, Alan
Mercer, Gavin
and
Johnstone, Eve C.
1997.
The use of videotaped assessment in relation to a study of enhanced management in treatment-resistant schizophrenia.
Journal of Psychopharmacology,
Vol. 11,
Issue. 4,
p.
357.
Lehmann, Heinz E
and
Ban, Thomas A
1997.
The History of the Psychopharmacology of Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 42,
Issue. 2,
p.
152.
Littrell, Steven H.
and
Littrell, Kimberly H.
1997.
Recent Advances in the Understanding of Negative Symptoms in Schizophrenia.
Journal of the American Psychiatric Nurses Association,
Vol. 3,
Issue. 4,
p.
111.
Hong, Walter W
Rak, Ihor W
Ciuryla, Vincent T
Wilson, Anastasia M
Kylstra, Jelle W
Meltzer, Herbert Y
Carpenter, William T
Lehman, Anthony
and
Arvanitis, Lisa A
1998.
Medical-claims databases in the design of a health-outcomes comparison of quetiapine (`Seroquel'1Seroquel is a trademark, the property of Zeneca Limited.1) and usual-care antipsychotic medication.
Schizophrenia Research,
Vol. 32,
Issue. 1,
p.
51.
Glaser, T.
Sommermeyer, H.
Faßbender, M.
and
Mauler, F.
1998.
Flupentixol — Typisches oder atypisches Wirkspektrum?.
p.
9.
Newman-Tancredi, Adrian
Gavaudan, Samantha
Conte, Caroline
Chaput, Christine
Touzard, Manuelle
Verrièle, Laurence
Audinot, Valerie
and
Millan, Mark J
1998.
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study.
European Journal of Pharmacology,
Vol. 355,
Issue. 2-3,
p.
245.
Duncan, Gary E
Leipzig, Jeremy N
Mailman, Richard B
and
Lieberman, Jeffery A
1998.
Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.
Brain Research,
Vol. 812,
Issue. 1-2,
p.
65.
Goren, Jessica L.
and
Levin, Gary M.
1998.
Quetiapine, an Atypical Antipsychotic.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 18,
Issue. 6,
p.
1183.
Wang, Rex Y
and
Arvanov, Viktor L
1998.
M100907, a highly selective 5-HT2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice.
Brain Research,
Vol. 779,
Issue. 1-2,
p.
309.
Kasper, S.
1998.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
489.
Honey, Garry D.
Bullmore, Edward T.
Soni, William
Varatheesan, Malini
Williams, Steve C. R.
and
Sharma, Tonmoy
1999.
Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.
Proceedings of the National Academy of Sciences,
Vol. 96,
Issue. 23,
p.
13432.
Markowitz, John S
Brown, Candace S
and
Moore, Thea R
1999.
Atypical Antipsychotics Part I: Pharmacology, Pharmacokinetics, and Efficacy.
Annals of Pharmacotherapy,
Vol. 33,
Issue. 1,
p.
73.
Atkins, Joshua B.
Chlan-Fourney, Jennifer
Nye, Heather E.
Hiroi, Noboru
Carlezon, William A.
and
Nestler, Eric J.
1999.
Region-specific induction of ?FosB by repeated administration of typical versus atypical antipsychotic drugs.
Synapse,
Vol. 33,
Issue. 2,
p.
118.
Reavill, C
Kettle, A
Holland, V
Riley, G
and
Blackburn, T P
1999.
Attenuation of haloperidol‐induced catalepsy by a 5‐HT2C receptor antagonist.
British Journal of Pharmacology,
Vol. 126,
Issue. 3,
p.
572.
Harrison, Paul J.
1999.
The neuropathology of schizophrenia.
Brain,
Vol. 122,
Issue. 4,
p.
593.
Riva, M.A.
Molteni, R.
Tascedda, F.
Massironi, A.
and
Racagni, G.
1999.
Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine.
Neuropharmacology,
Vol. 38,
Issue. 7,
p.
1075.
Hellewell, J S E
Kalali, A H
Langham, S J
McKellar, J
and
Awad, A G
1999.
Patient satisfaction and acceptability of long-term treatment with quetiapine.
International Journal of Psychiatry in Clinical Practice,
Vol. 3,
Issue. 2,
p.
105.
Sakaue, M
Somboonthum, P
Nishihara, B
Koyama, Y
Hashimoto, H
Baba, A
and
Matsuda, T
2000.
Postsynaptic 5‐hydroxytryptamine1A receptor activation increases in vivo dopamine release in rat prefrontal cortex.
British Journal of Pharmacology,
Vol. 129,
Issue. 5,
p.
1028.
Scatton, B.
and
Sanger, D.J.
2000.
Pharmacological and molecular targets in the search for novel antipsychotics.
Behavioural Pharmacology,
Vol. 11,
Issue. 3 & 4,
p.
243.
Tascedda, Fabio
Blom, Joan M.C
Brunello, Nicoletta
Zolin, Katia
Gennarelli, Massimo
Colzi, Anna
Bravi, Daniele
Carra, Serena
Racagni, Giorgio
and
Riva, Marco A
2001.
Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats.
Biological Psychiatry,
Vol. 50,
Issue. 2,
p.
117.
eLetters
No eLetters have been published for this article.